Groupe la Francaise »

Theravance Biopharma shares owned by Groupe la Francaise

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Groupe la Francaise from 13F filings

Historical chart of Groupe la Francaise investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Groupe la Francaise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Groupe la Francaise

Quarter filed Position value Share count Share price at filing
2026-06-30 $510k 30k 17.00

More positions owned by Groupe la Francaise

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Totalenergies Se Act (TTE)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Astrazeneca Ord (AZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Cgi Cl A Sub Vtg (GIB)

View all positions for Groupe la Francaise

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma